Kaya, Prodita .

HRN: 13-61-00  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/09/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/09/2026
01/16/2026
IV
4.5g
Q8HRS
Severe TBI (GCS 3) Sec To RCI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft TissueCentral Nervous System    Compliance to guidelines: Compliant To Guidelines